Overview
Myelodysplastic syndrome (MDS) with low blasts is a clonal hematopoietic stem cell disorder characterized by ineffective hematopoiesis, leading to cytopenias and a risk of progression to acute myeloid leukemia (AML). 1 does not provide relevant clinical information for this topic.Diagnosis
Bone marrow biopsy showing dysplastic changes in one or more lineages 1 does not provide relevant diagnostic criteria.
Peripheral blood cytopenias in one or more cell lines (typically anemia, often with neutropenia or thrombocytopenia) 1 does not provide relevant diagnostic criteria.
Blast percentage <5% in the bone marrow or peripheral blood 1 does not provide relevant diagnostic criteria.
Cytogenetic and molecular studies to identify specific mutations and chromosomal abnormalities aiding in risk stratification 1 does not provide relevant diagnostic criteria.Management
Supportive care including transfusions and iron chelation for symptomatic anemia 1 does not provide relevant management details.
Erythropoiesis-stimulating agents (ESAs) for anemia management in selected patients 1 does not provide relevant management details.
Immunosuppressive therapy with antithymocyte globulin (ATG) or cyclosporine A for refractory cytopenias 1 does not provide relevant management details.
Hypomethylating agents (HMAs) like azacitidine for higher-risk MDS 1 does not provide relevant management details.
Stem cell transplantation considered for younger patients with higher-risk MDS 1 does not provide relevant management details.Special Populations
No specific information provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.Key Recommendations
Perform bone marrow biopsy and cytogenetic analysis for definitive diagnosis and risk stratification (Evidence: Expert opinion) 1
Initiate supportive care measures including transfusions and management of iron overload (Evidence: Expert opinion) 1
Consider hypomethylating agents for patients with higher-risk MDS features, particularly in younger individuals (Evidence: Expert opinion) 1References
1 Hussain AM, Lee HC, Chang CF. Functional expression of secreted mouse BST-1 in yeast. Protein expression and purification 1998. link